| Israel exports to India · Acids: saturated acyclic monocarboxylic acids: esters of acetic acid n.e.s. in item no. 2915.3 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Acids: saturated acyclic monocarboxylic acids: anhydrides, halides, peroxides, peroxyacids and halogenated, sulphonated, nitrated or nitrosated derivatives, n.e.s. in heading no. 2915 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Singapore · Acids: saturated acyclic monocarboxylic acids: anhydrides, halides, peroxides, peroxyacids and halogenated, sulphonated, nitrated or nitrosated derivatives, n.e.s. in heading no. 2915 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Acids: aromatic polycarboxylic acids: phthalic anhydride | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Acids: carboxylic acids, (with alcohol function but without other oxygen function), citric acid | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Acids: carboxylic acids, (with alcohol function but without other oxygen function), salts and esters of citric acid | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Acids: carboxylic acids, (with alcohol function but without other oxygen function), salts and esters of citric acid | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Acids: carboxylic acids, (with alcohol function but without other oxygen function), n.e.s. in item no. 2918.1 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Chile · Acids: carboxylic acids, (with alcohol function but without other oxygen function), n.e.s. in item no. 2918.1 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Acids: carboxylic acids, (with alcohol function but without other oxygen function), n.e.s. in item no. 2918.1 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Acids: carboxylic acids, (with phenol function but without other oxygen function), their anhydrides, halides, peroxides, peroxyacids and their derivatives, n.e.s. in item no. 2918.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Acids: carboxylic acids, (with phenol function but without other oxygen function), their anhydrides, halides, peroxides, peroxyacids and their derivatives, n.e.s. in item no. 2918.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Singapore · Acids: carboxylic acids, (with phenol function but without other oxygen function), their anhydrides, halides, peroxides, peroxyacids and their derivatives, n.e.s. in item no. 2918.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Acids: carboxylic acids, with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids, n.e.s. in heading no. 2918 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Acids: carboxylic acids, with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids, n.e.s. in heading no. 2918 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Amine-function compounds: aromatic monoamines and their derivatives: salts thereof: n.e.s. in item no. 2921.4 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Amino-alcohols, their ethers and esters: (other than those containing more than one kind of oxygen function), n.e.s. in item no. 2922.1 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Amino-naphthols and other amino-phenols: their ethers and esters, (other than those containing more than one kind of oxygen function), n.e.s. in item no. 2922.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Amino-acids: their esters, (other than those containing more than one kind of oxygen function), n.e.s. in item no. 2922.4 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Lecithins and other phosphoaminolipids | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Acyclic amides (including acyclic carbamates) and their derivatives: salts thereof | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Cyclic amides (including cyclic carbamates) and their derivatives, ureines and their derivatives: salts thereof | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Italy · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Nitrile-function compounds: n.e.s. in heading no. 2926 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Organic derivatives of hydrazine or of hydroxylamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Organic derivatives of hydrazine or of hydroxylamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Austria · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to New Zealand · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Peru · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: containing an unfused furan ring (whether or not hydrogenated) in the structure, n.e.s. in item no. 2932.10 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Heterocyclic compounds: n.e.s. in heading no. 2932 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Italy · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Colombia · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to New Zealand · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylurea | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Chile · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Hungary · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to New Zealand · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Slovakia · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Heterocyclic compounds: n.e.s. in heading no. 2933 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Heterocyclic compounds: containing an unfused thiazole ring (whether or not hydrogenated) in the structure | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Hungary · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Poland · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Vitamins: vitamins A and their derivatives, unmixed | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Hormones and steroids used primarily as hormones: (other than insulin and its salts, oestrogens and progestogens) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Antibiotics: n.e.s. in heading no. 2941 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Organic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Organic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Hungary · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Romania · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Sweden · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Thailand · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Belarus · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Czechia · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
Research Data